SNO 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Children's National Hospital at SNO 2026

Nov 12–15, 2026 Philadelphia, PA ~3k attendees Website

Children's National Hospital brings 19 presentations to SNO 2026 in Philadelphia. Its program leans toward experimental therapeutics for pediatric brain tumors, especially engineered CAR-T cell therapies. It also teaches in the Neuro-Oncology Review Course and builds preclinical models for ultra-rare pediatric tumors.

OrganizationSNO 2026 Attendance
Hospitals & cancer centers
A pediatric hospital and research center with programs in childhood brain tumors, neurosurgery, and neuro-oncology.
Session
Wed Nov 11
8:30–10:40am
Neuro-Oncology Review Course -- Session 1
Terrace Ballroom I Convention Center
Session
Wed Nov 11
10:55am–1pm
Neuro-Oncology Review Course -- Session 2
Terrace Ballroom I Convention Center
Session
Wed Nov 11
1:40–2:55pm
Neuro-Oncology Review Course -- Session 3
Terrace Ballroom I Convention Center
Session
Wed Nov 11
3:10–4:35pm
Neuro-Oncology Review Course -- Session 4
Terrace Ballroom I Convention Center
Talk
Fri Nov 13
12–12:03pm
Talk
Fri Nov 13
12:15–12:18pm
An NF1-Deficient Brain Organoid Microenvironment Enhances Glioma Progression via Cytokines
Exhibit Hall D & E, Second Floor, Convention Center · Abstract TMOD-15
Therapeutics
Talk
Fri Nov 13
12:21–12:24pm
Optimizing CAR T Cell Therapy for Pediatric Glioma Through Pharmacologic Modulation of DNA Methylation During Manufacturing
Exhibit Hall D & E, Second Floor, Convention Center · Abstract IMMU-11
Immunology
Talk
Fri Nov 13
2:44–2:51pm
Talk
Fri Nov 13
3:45–4:45pm
Session
Fri Nov 13
7:30–9:30pm
Poster Session
Exhibit Hall D & E, Second Floor, Convention Center
Poster
Fri Nov 13
7:30–9:30pm
Poster
Fri Nov 13
7:30–9:30pm
Pilot study to investigate optimal dose of microtubule-destabilizing agent AUS001 in mice bearing diffuse midline glioma allograft tumors
Exhibit Hall D & E, Second Floor, Convention Center · Abstract EXTH-32
Therapeutics
Poster
Fri Nov 13
7:30–9:30pm
In vitro and in vivo evaluation of CT-179 in combination with ONC201 and ONC206 in patient-derived models of diffuse midline glioma
Exhibit Hall D & E, Second Floor, Convention Center · Abstract EXTH-33
Therapeutics
Poster
Fri Nov 13
7:30–9:30pm
Developing CAMKv CAR T-cell therapy for treating MYC-associated pediatric brain tumors
Exhibit Hall D & E, Second Floor, Convention Center · Abstract EXTH-63
Therapeutics
Poster
Fri Nov 13
7:30–9:30pm
Enhancing CAR Signaling and Immune Synapse Formation Through TCR Co-Expression Against Pediatric High-Grade Gliomas
Exhibit Hall D & E, Second Floor, Convention Center · Abstract IMMU-46
Immunology
Poster
Fri Nov 13
7:30–9:30pm
Sonic Hedgehog Signaling Drives Retinoblastoma Tumorigenesis and Represents a Therapeutic Vulnerability
Exhibit Hall D & E, Second Floor, Convention Center · Abstract TMOD-07
Therapeutics
Poster
Fri Nov 13
7:30–9:30pm
Establishing Patient-Derived and iPSC–Organoid Models of High-Risk Childhood Astroblastoma
Exhibit Hall D & E, Second Floor, Convention Center · Abstract TMOD-28
Therapeutics
Plenary
Sat Nov 14
8:30–10am
Part of Plenary III
2026 SNO Lifetime Achievement Award Recipient
Exhibit Hall C, Second Floor, Convention Center
Talk
Sat Nov 14
11:42–11:45am
Learning From Every Rare Case: The Early Impact of an International Pediatric Rare Brain Tumor Board
Exhibit Hall D & E, Second Floor, Convention Center · Abstract INNV-30
Survivorship

Explore the full SNO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Philadelphia. Leave your work email and we’ll be in touch.

Privacy

Download the full SNO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Children's National Hospital

Tell us what you sell and we’ll find the people at Children's National Hospital most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the Society for Neuro-Oncology. Submit a correction